|
Sponsor
|
Study ID ↑
|
Description
|
Created
|
| |
|
*ASTELLAS-9463-EC-0002
|
An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis Versus Placebo in High Risk Surgical Subjects with Intra-abdominal Infections - A Multicentre, Randomized, Double-blind Study
|
7/31/2017
|
| |
|
*BAYER-15786
|
A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation StrategieS).
|
4/18/2019
|
| |
|
*BAYER-B078
|
Five-year Clinical Performance of the New Formulation of the Levonorgestrel Intrauterine System and Serum Levonorgestrel Concentration with the New Formulation Compared to That with the Original One.
|
11/30/2016
|
| |
|
*EISAI-E2007-A001-206
|
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-235
|
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to Less Than 18 Years of Age) With Inadequately Controlled Partial-onset Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-304
|
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-305
|
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-306
|
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-332
|
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
|
11/30/2018
|
| |
|
*EISAI-E2007-G000-332EXT
|
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
|
11/30/2018
|